Cairn Investment Group’s GSK GSK Stock Holding History

Cairn Investment Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,800	Closed	-$533K	–	76
2022 Q2	$533K	Sell	9,800 -120	-1%	-$6.63K	0.41%	52
2022 Q1	$660K	Sell	9,920 -60	-0.6%	-$3.26K	0.42%	53
2021 Q4	$550K	Sell	9,980 -1,548	-13%	-$80.5K	0.38%	51
2021 Q3	$550K	Sell	11,528 -64	-0.6%	-$3.21K	0.41%	50
2021 Q2	$576K	Sell	11,592 -2,164	-16%	-$104K	0.42%	51
2021 Q1	$614K	Sell	13,756 -1,000	-7%	-$45.4K	0.51%	49
2020 Q4	$679K	Sell	14,756 -760	-5%	-$34.9K	0.64%	46
2020 Q3	$730K	Sell	15,516 -1,680	-10%	-$84.2K	0.77%	45
2020 Q2	$876K	Sell	17,196 -416	-2%	-$21.3K	1.06%	42
2020 Q1	$834K	Sell	17,612 -1,280	-7%	-$68.3K	1.24%	34
2019 Q4	$1.11M	Buy	+18,892	New	+$1.05M	1.1%	39

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cairn Investment Group's GSK Position: Q3 2022 in Review

Cairn Investment Group sold out of GSK (GSK) in Q3 2022, closing a stake of 9,800 shares — an estimated $533K sold.

Cairn Investment Group first reported a position in GSK in Q4 2019 and held it in 11 quarters. The position peaked at $1.11M in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Cairn Investment Group reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Cairn Investment Group sold 9,800 GSK shares in Q3 2022, an estimated $533K.
Cairn Investment Group first reported a position in GSK in Q4 2019 and held it in 11 quarters.
Cairn Investment Group's GSK position peaked at $1.11M in Q4 2019.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Cairn Investment Group's 13F filing for Q3 2022, filed 13 Oct 2022.